Your session is about to expire
← Back to Search
Exparel/Intervention group for Opioid Use Disorder
Phase 3
Waitlist Available
Led By Thomas K Miller, MD
Research Sponsored by Carilion Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18-65 years old
Presenting to Carilion Clinic Institute of Orthopedics and Neuroscience
Timeline
Screening 3 weeks
Treatment Varies
Follow Up self reported anytime from immediately post-op until 2 weeks post-operatively. likely 1-3 days
Awards & highlights
Study Summary
This study is evaluating whether a local anesthetic injection may help reduce pain for individuals who have had ACL surgery.
Eligible Conditions
- Anterior Cruciate Ligament Tear
- Opioid Use Disorder
- Postoperative Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ self reported anytime from immediately post-op until 2 weeks post-operatively. likely 1-3 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~self reported anytime from immediately post-op until 2 weeks post-operatively. likely 1-3 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Total opioid consumption
Secondary outcome measures
Block length
Pain control quantified by intervention-based pain scale
Pain control quantified by numerical rating scale
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exparel/Intervention groupExperimental Treatment2 Interventions
Will receive 10mL of standard 0.5% bupivacaine followed by 10mL of liposomal bupivacaine as adductor canal field block preoperatively
Group II: Standard of Care groupActive Control1 Intervention
Will receive 20mL of standard 0.5% bupivacaine as adductor canal field block preoperatively
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Bupivacaine
FDA approved
Find a Location
Who is running the clinical trial?
Carilion ClinicLead Sponsor
70 Previous Clinical Trials
12,655 Total Patients Enrolled
Thomas K Miller, MDPrincipal InvestigatorCarilion Clinic
1 Previous Clinical Trials
17 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger